Citigroup Inc Care Dx, Inc. Transaction History

Citigroup Inc

$150 Billion
Q1 2024

A detailed history of Citigroup Inc transactions in Care Dx, Inc. stock. As of the latest transaction made, Citigroup Inc holds 391,821 shares of CDNA stock, worth $5.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

391,821

Previous 82,737 373.57%

Holding current value

$5.1 Million

Previous $992,000 318.25%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$7.96 - $12.37 $2.46 Million - $3.82 Million	309,084 Added 373.57%	391,821 $4.15 Million
Q4 2023 Feb 09, 2024	SELL	$4.9 - $12.86 $244,132 - $640,723	-49,823 Reduced 37.59%	82,737 $992,000
Q3 2023 Nov 09, 2023	BUY	$7.0 - $11.26 $61,376 - $98,727	8,768 Added 7.08%	132,560 $927,000
Q2 2023 Aug 10, 2023	SELL	$7.61 - $9.46 $1.56 Million - $1.94 Million	-204,771 Reduced 62.32%	123,792 $1.05 Million
Q1 2023 May 11, 2023	BUY	$8.83 - $17.61 $960,783 - $1.92 Million	108,809 Added 49.51%	328,563 $3 Million

Q4 2022 Feb 09, 2023	SELL	$10.88 - $20.05 $552,867 - $1.02 Million	-50,815 Reduced 18.78%	219,754 $2.51 Million
Q3 2022 Nov 10, 2022	BUY	$16.06 - $26.39 $1.45 Million - $2.39 Million	90,455 Added 50.22%	270,569 $4.61 Million
Q2 2022 Aug 10, 2022	BUY	$20.49 - $39.72 $2.82 Million - $5.46 Million	137,558 Added 323.24%	180,114 $3.87 Million
Q1 2022 May 12, 2022	SELL	$28.19 - $46.6 $2.08 Million - $3.44 Million	-73,740 Reduced 63.41%	42,556 $1.58 Million
Q4 2021 Feb 10, 2022	BUY	$41.2 - $73.6 $2.76 Million - $4.94 Million	67,057 Added 136.19%	116,296 $5.29 Million
Q3 2021 Nov 10, 2021	BUY	$59.15 - $91.99 $2.91 Million - $4.53 Million	49,239 New	49,239 $3.12 Million

Others Institutions Holding CDNA

# of Institutions

150

Shares Held

55.1M

Call Options Held

85.8K

Put Options Held

48.8K

View Full List

About CareDx, Inc.

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $695M
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

More about CDNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account